Oral Medication Preserves Brain Volume in Early Alzheimer’s Patients
Yes, a new oral medication called blarcamesine has demonstrated the ability to preserve brain volume in early Alzheimer's disease patients.
Category Games
Medical Device Standards Set for Alzheimer’s Brain Scan Implementation
The FDA has established a comprehensive framework of medical device standards for Alzheimer's diagnostic imaging that fundamentally changes how doctors...
Researchers Find Molecular Kill Switch Involved in Alzheimer’s Brain Damage
Researchers have identified a "molecular kill switch" in the Alzheimer's disease brain—a toxic protein complex formed when TRPM4 ion channels abnormally...
Short Daily Brain Health Exercises May Reduce Dementia Risk
Short daily brain health exercises—specifically cognitive speed training—can reduce your dementia risk by approximately 25% over the next two decades,...
Brain Imaging Advances Enhance Alzheimer’s Screening Programs
Recent advances in brain imaging technology are fundamentally transforming Alzheimer's disease screening, enabling clinicians to detect the disease at...
Sorority Partners With National Organization to Address Brain Health Disparities
The Alzheimer's Association has partnered with Sigma Gamma Rho Sorority, Inc., one of the largest historically Black sororities, to directly address...
Scientists Explain How Existing Alzheimer’s Drug Clears Brain Plaques
Scientists have made a significant breakthrough in understanding how lecanemab, an FDA-approved Alzheimer's drug, effectively clears toxic amyloid plaques...
$2.8 Million Federal Grant Funds Brain Training Study to Prevent Dementia
A $2.8 million federal grant from the National Institutes of Health is funding continued research into a promising approach: computerized brain training...
Brain Cell Communication Pathway Identified as Alzheimer’s Defense Mechanism
Researchers at UCLA Health and UC San Francisco have identified a protein complex called CRL5SOCS4 that represents a natural Alzheimer's defense...
Brain Volume Data Supports Efficacy of Oral Alzheimer’s Drug
Brain volume data provides compelling evidence that oral Alzheimer's drugs can slow neurodegeneration in early-stage disease.